Predicting onset and continuity of patient-reported symptoms in cancer patients undergoing immune checkpoint inhibitor (ICI) therapies using machine learning

Authors
Category Primary study
JournalAnnals of Oncology
Year 2019
This article has no abstract
Epistemonikos ID: adb2fccd669c77700b22c8c5c69b5b510b19a0b9
First added on: Feb 11, 2025